Buds & Duds: Analysts call for cannabis sector's bottom; stocks stay quiet

The grass is going to get greener for Canadian cannabis producers, say analysts at Cantor Fitzgerald

pot leaves
Making moves on Wednesday were Mojave Jane, PharmaCielo and TransCanna

Cannabis stocks stayed quiet on Wednesday after analysts called the bottom of the sector’s woes.

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada fell 1.4% at 127.4 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF decreased by 0.5% to C$10.50, while the OTCQX Cannabis Index was up 0.4% to 446.5 points.


The grass is going to get greener for Canadian cannabis producers, say analysts at Cantor Fitzgerald. It’s only a matter of time.

Valuations are at two-year lows, the firm said in a research note on Monday, and positive catalysts outweigh negative ones over the next year.

On Wednesday Colombian cannabis producer PharmaCielo Ltd (CVE:PCLO) (OTCMKTS:PHCEF) saw its shares shoot higher after it issued an update saying it was terminating its proposed transaction with Australia’s Creso Pharma Limited after advisory firm BDO concluded that the acquisition was neither “fair nor reasonable” to Creso’s shareholders.

"While we are disappointed by this outcome, we have appreciated the interactions between our teams over the past several months and wish them much success in their future endeavours," said David Attard, CEO of PharmaCielo.

Investors sent the company’s shares up 14.5% to C$3.55 in Canada and 18.1% on OTC markets at US$2.74.

Meanwhile, Mojave Jane Brands Inc (CSE:JANE) (OTCMKTS:HHPHF) was also up 7.7% at C$0.07 in Canada as it said it hired Clearview Capital Consult for communications and strategic advisory services.

The vertically integrated cannabis company said Clearview will assist with the development and implementation of its capital markets and communications strategy, along with general strategic advisory.

Harvest One Cannabis Inc (CVE:HVT) (OTCMKTS:HRVOF) also gained 3.3% in Canada at C$0.31 after its subsidiary Satipharm Ltd received Health Canada's permission to import its proprietary CBD Gelpell capsules for research and development.


TransCanna Holdings Inc (CSE:TCAN) sank on Wednesday morning despite hitting its initial revenue target for October.

In September and October, the company built out its infrastructure by doubling the production capacity for SolDaze and Lyfted Farms business units. The first monthly revenue numbers for October exceeded C$250,000 and the company will continue to scale the production and revenues in the coming months, the company said in a statement.

Shares of TransCanna fell 12.2% at C$0.86.

Over on the big board in Toronto, Charlotte’s Web Holdings Inc (TSE:CWEB) lost 6.3% at C$14.49 and 6% on OTC markets at US$11.01 ahead of its quarterly earnings report due next week.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Mandalay Resources latest drilling shows impressive results from Youle...

Mandalay Resources (TSE: MND-OTCQB: MNDJF) President and CEO Dominic Duffy joined Steve Darling from Proactive with news the company has seen some very strong numbers from the latest drill results on the Youle Deposit at their Costerfield Project. Duffy telling Proactive the numbers returned...

1 day, 23 hours ago

3 min read